EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early and mature Achromobacter xylosoxidans biofilm in cystic fibrosis and non-cystic fibrosis isolates: dynamics and response to clinically relevant antibiotics

Vincent Jean-Pierre, Pauline Sorlin, Catherine Dunyach-Remy, Florian Salipante, Raphaël Chiron, Jean-Philippe Lavigne, Cassandra Pouget, Hélène Marchandin

Biofilm · 2026-12 · 12 · 100375

DOI: 10.1016/j.bioflm.2026.100375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biofilm, 2026-12. Verfasst von Vincent Jean-Pierre und 7 weiteren Autor:innen. Beteiligte Einrichtung: HydroSciences Montpellier, Université de Montpellier, CNRS, IRD, Service de Microbiologie et Hygiène Hospitalière, CHU de Nîmes, Montpellier, 34093, …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre Hospitalier Universitaire de Nîmes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Achromobacter xylosoxidans is an opportunistic pathogen in both cystic fibrosis (CF) and non-CF patients, in whom biofilm formation contributes to bacterial persistence and antibiotic tolerance. This study aimed to characterize early and mature biofilm formation in 57 clinical A. xylosoxidans isolates using complementary and physiologically relevant approaches and to compare biofilm phenotypes according to isolate origin (CF/non-CF). Early adhesion was assessed using the Biofilm Ring Test®, mature biofilm viable biomass was quantified under static conditions by colony-forming units counts, and biofilm dynamics were analyzed in a continuous-flow microfluidic system. The effects of five clinically relevant antibiotics (trimethoprim-sulfamethoxazole, piperacillin-tazobactam, meropenem, imipenem, and cefiderocol) were evaluated under dynamic conditions at sub-inhibitory concentrations (0.5 × Minimum Inhibitory Concentration (MIC)) and on preformed biofilm at inhibitory concentrations (10 × MIC). Non-CF isolates displayed faster early adhesion than CF isolates, whereas mature biofilm biomass was comparable between groups. If early adhesion did not predict mature biofilm biomass, dynamic biofilm coverage under flow conditions correlated with static mature biofilm levels. Sub-inhibitory antibiotic concentrations failed to prevent initial adhesion and elicited three distinct responses: biofilm formation enhancement (piperacillin-tazobactam, meropenem, imipenem), no effect (trimethoprim-sulfamethoxazole), or biofilm reduction (cefiderocol). Exposing mature biofilm to 10 × MIC identified trimethoprim-sulfamethoxazole and cefiderocol as the most effective agents in biofilm biomass reduction, whereas carbapenems and piperacillin-tazobactam were less effective. These findings provide new insights into A. xylosoxidans biofilm biology and may help guide therapeutic strategies for infections caused by this emerging, increasingly drug-resistant pathogen.

Schlagwörter

Stichwörter der Autor:innen

Achromobacter xylosoxidansAntibiofilmAntibioticBiofilmCystic fibrosisEarly adhesionMicrofluidic flow system

Autor:innen und Institutionen

  • HydroSciences Montpellier, Université de Montpellier, CNRS, IRD, Service de Microbiologie et Hygiène Hospitalière, CHU de Nîmes, Montpellier, 34093, France.
  • Hospital Hygiene and Infection Control Team, Hospital Center Laval, Laval, 53000, France.
  • VBIC, Univ Montpellier, INSERM, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Nîmes, France.
  • Service de Biostatistique, Épidémiologie, Santé Publique, et Information Médicale, Université de Montpellier, CHU Nîmes, Nîmes, 30900, France.
  • HydroSciences Montpellier, Université de Montpellier, CNRS, IRD, Centre de Ressources et de Compétences de la Mucoviscidose, CHU de Montpellier, Montpellier, 34093, France.

Förderung

  • Centre Hospitalier Universitaire de Nîmes

Zitieren

APA

Jean-Pierre, V., Sorlin, P., Dunyach-Remy, C., Salipante, F., Chiron, R., Lavigne, J. P., Pouget, C., & Marchandin, H. (2026). Early and mature Achromobacter xylosoxidans biofilm in cystic fibrosis and non-cystic fibrosis isolates: dynamics and response to clinically relevant antibiotics. Biofilm, 12, 100375. https://doi.org/10.1016/j.bioflm.2026.100375

Vancouver

Jean-Pierre V, Sorlin P, Dunyach-Remy C, Salipante F, Chiron R, Lavigne JP, et al. Early and mature Achromobacter xylosoxidans biofilm in cystic fibrosis and non-cystic fibrosis isolates: dynamics and response to clinically relevant antibiotics. Biofilm. 2026;12:100375. doi:10.1016/j.bioflm.2026.100375

BibTeX
@article{JeanPierre2026,
  author = {Jean-Pierre, Vincent and Sorlin, Pauline and Dunyach-Remy, Catherine and Salipante, Florian and Chiron, Raphaël and Lavigne, Jean-Philippe and Pouget, Cassandra and Marchandin, Hélène},
  title = {Early and mature Achromobacter xylosoxidans biofilm in cystic fibrosis and non-cystic fibrosis isolates: dynamics and response to clinically relevant antibiotics},
  journal = {Biofilm},
  year = {2026},
  volume = {12},
  pages = {100375},
  doi = {10.1016/j.bioflm.2026.100375}
}
Kostenlos starten →